L.i. 14 - analogs
| Prices in pharmacies: Instructions L.i. 14 | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Atorvastatin ✘ (incl) Digoxin ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 45% L.i. 13 neutral
- 26% Si 18 neutral
- 24% Gb 16 neutral
- 19% Gb 14 neutral
- 19% Bl 1 neutral
- 18% St 3 neutral
- 17% Gb 1 neutral
- 17% Du 23 neutral
- 16% Tb 23 neutral
- 16% Si 3 neutral
- 16% Si 6 neutral
- 16% Du 9 neutral
- 16% Gb 15 neutral
- 15% Si 5 neutral
- 15% Gb 18 neutral
- 15% Tb 4 neutral
- 15% St 5 neutral
- 14% L.i. 20 neutral
- 14% L.i. 2 neutral
- 14% St 2 neutral
- 14% L.i. 15 neutral
- 14% Bl 9 neutral
- 13% Gb 6 neutral
- 13% Si 16 neutral
- 13% Du 24 neutral
- 13% Tb 2 neutral
- 13% Si 15 neutral
- 13% Bl 19 neutral
- 12% Gb 41 neutral
- 12% St 1 neutral
- 12% L.i. 5 neutral
- 12% Gb 36 neutral
- 12% Tb 16 neutral
- 12% Gb 42 neutral
- 12% Gb 17 neutral
- 11% Tb 3 neutral
- 11% L.i. 1 neutral
- 11% Tb 17 neutral
- 11% He 9 neutral
- 11% Si 8 neutral
- 11% L.i. 10 neutral
- 11% PC151 Вай-хуай-цзянь neutral
- 10% He 5 neutral
- 10% Bl 10 neutral
- 10% St 32 neutral
- 10% St 43 neutral
- 10% Tb 10 neutral
- 10% Liv 5 neutral
- 10% Du 15 neutral
- 10% Bl 61 neutral
Learn more about the selection of analogues
- The drug has «L.i. 14» no complete analogues; 51 analog by action, the most similar - L.i. 13 .
- Medical online service has selected the best substitutes for L.i. 14 based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues L.i. 14 to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.